ENCORE

Serial Number 88294863
Registration 5882794
702

Registration Progress

Application Filed
Feb 8, 2019
Under Examination
Approved for Publication
Jul 30, 2019
Published for Opposition
Jul 30, 2019
Registered
Oct 15, 2019

Attorney Assistance

Section 8 Declaration Due (Principal Register) (Based on registration date 20191015) (Grace Period Filing)
Due: Apr 15, 2026 Grace Period - 115 days
Original deadline was Oct 15, 2025 (overdue)

Trademark Image

ENCORE

Basic Information

Serial Number
88294863
Registration Number
5882794
Filing Date
February 8, 2019
Registration Date
October 15, 2019
Published for Opposition
July 30, 2019
Drawing Code
3

Status Summary

Current Status
Active
Status Code
702
Status Date
May 14, 2025
Registration
Registered
Classes
042

Rights Holder

PHARMALINK, LLC

16
Address
8285 BRYAN DAIRY RD. SUITE 200
LARGO, FL 33777

Ownership History

Pharmalink, Inc.

Original Applicant
03
Largo, FL

Pharmalink, Inc.

Owner at Publication
03
Largo, FL

Pharmalink, Inc.

Original Registrant
03
Largo, FL

PHARMALINK, LLC

New Owner After Registration #1
16
LARGO, FL

Legal Representation

Attorney
Nathan P. Suedmeyer

USPTO Deadlines

Next Deadline
In Grace Period
Section 8 Declaration Due (Principal Register) (Based on registration date 20191015)
Due Date
October 15, 2025
Grace Period Ends
April 15, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

33 events
Date Code Type Description Documents
Aug 14, 2025 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Aug 6, 2025 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
May 14, 2025 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
May 14, 2025 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
May 14, 2025 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Jan 22, 2025 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Oct 15, 2024 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Oct 15, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jul 30, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 30, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 10, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 24, 2019 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 20, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 19, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 19, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 13, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 13, 2019 GNRT O NON-FINAL ACTION E-MAILED Loading...
Jun 13, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 13, 2019 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN Loading...
May 28, 2019 PBCR Z WITHDRAWN FROM PUB - OG REVIEW QUERY Loading...
May 16, 2019 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
May 16, 2019 ALIE A ASSIGNED TO LIE Loading...
May 1, 2019 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 30, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 29, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 29, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Apr 29, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 29, 2019 GNRT F NON-FINAL ACTION E-MAILED Loading...
Apr 29, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 22, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 21, 2019 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Mar 11, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 12, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Providing on-line non-downloadable software for identifying, managing, controlling, reconciling, reporting, analyzing, preparing, processing, recalling, and disposing of product returns in a web-based reverse logistics software suite of applications for use by pharmacies, hospitals, physicians, manufacturers, wholesalers, and other healthcare-related entities
First Use Anywhere: Feb 8, 2019
First Use in Commerce: Feb 8, 2019

Additional Information

Design Mark
The mark consists of the wording "encorRe" with a diagonal brushstroke through the diagonal leg of the letter "R" forming an "RX" prescription symbol.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
ENCORE RX ENCORXE

Classification

International Classes
042